{"filing":{"accession_number":"0001104659-26-082947","cik":"0001027838","ticker":"TCMD","company_name":"TACTILE SYSTEMS TECHNOLOGY INC","form":"8-K","filing_date":"2026-07-13","report_date":null,"primary_document":"tm2620304d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1027838/000110465926082947/tm2620304d1_8k.htm"},"events":[{"id":17541,"run_id":15712,"accession_number":"0001104659-26-082947","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"Tactile Medical announced an exclusive U.S. distribution agreement with ElastiMed for the MyoSleeve wearable compression device targeting VA and DoD patients, with a $3 million upfront payment and commitments to minimum purchase obligations and marketing support. This material strategic partnership expands the company's product portfolio and market reach.","company_name":"TACTILE SYSTEMS TECHNOLOGY INC","ticker":"TCMD","filing_date":"2026-07-13","form":"8-K","submitted_at":null,"items":[{"id":16051,"accession_number":"0001104659-26-082947","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Tactile Medical announced an exclusive U.S. distribution agreement with ElastiMed for the MyoSleeve wearable compression device targeting VA and DoD patients. The company made a $3 million upfront payment and committed to minimum purchase obligations and marketing support. This is a material strategic partnership that expands the company's product portfolio and market reach, but does not fit the specific categories of M\u0026A activity, debt issuance, or other defined event types—it is a material operational/commercial agreement that warrants disclosure under Regulation FD.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T13:24:39.902187+00:00","company_name":"","ticker":null,"filing_date":""},{"id":16052,"accession_number":"0001104659-26-082947","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Tactile Medical announced an exclusive distribution agreement with ElastiMed to commercialize MyoSleeve, a wearable compression device, within VA and DoD systems. The company made a $3 million upfront payment and committed to minimum purchase obligations and marketing support. This is a material strategic partnership and product expansion that would affect investor assessment of the company's growth prospects and market positioning, but it does not fit the specific categories of M\u0026A activity (no acquisition or change of control), debt issuance, or other defined event types—it is a material operational/commercial partnership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T13:24:39.902187+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16051,"accession_number":"0001104659-26-082947","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Tactile Medical announced an exclusive U.S. distribution agreement with ElastiMed for the MyoSleeve wearable compression device targeting VA and DoD patients. The company made a $3 million upfront payment and committed to minimum purchase obligations and marketing support. This is a material strategic partnership that expands the company's product portfolio and market reach, but does not fit the specific categories of M\u0026A activity, debt issuance, or other defined event types—it is a material operational/commercial agreement that warrants disclosure under Regulation FD.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T13:24:39.902187+00:00","company_name":"TACTILE SYSTEMS TECHNOLOGY INC","ticker":"TCMD","filing_date":"2026-07-13"},{"id":16052,"accession_number":"0001104659-26-082947","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"Tactile Medical announced an exclusive distribution agreement with ElastiMed to commercialize MyoSleeve, a wearable compression device, within VA and DoD systems. The company made a $3 million upfront payment and committed to minimum purchase obligations and marketing support. This is a material strategic partnership and product expansion that would affect investor assessment of the company's growth prospects and market positioning, but it does not fit the specific categories of M\u0026A activity (no acquisition or change of control), debt issuance, or other defined event types—it is a material operational/commercial partnership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T13:24:39.902187+00:00","company_name":"TACTILE SYSTEMS TECHNOLOGY INC","ticker":"TCMD","filing_date":"2026-07-13"}]}